⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALKS News
Alkermes Inc. plc
Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc
prnewswire.com
ALKS
AVDL
Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”
globenewswire.com
AVDL
ALKS
Alkermes Response to Avadel Announcement USA - English USA - English
prnewswire.com
ALKS
Avadel Receives Unsolicited Proposal from Lundbeck
globenewswire.com
AVDL
ALKS
Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2 USA - English USA - English
prnewswire.com
ALKS
Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2
prnewswire.com
ALKS
Alkermes to Participate in Two Upcoming Investor Conferences
prnewswire.com
ALKS
FORM 8.1(a) & (b) (Opening Position Disclosure)
prnewswire.com
ALKS
Alkermes plc Reports Third Quarter 2025 Financial Results
prnewswire.com
ALKS
ALKS
Alkermes Appoints Joshua Reed as Chief Financial Officer
prnewswire.com
ALKS
ALKS